Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS): A Randomized, Controlled, Multi-center, Prospective Study Evaluating Dose Reduction in ITB Patients.

NCT04530955 is registered in ClinicalTrials.gov with Culicchia Neurological Clinic as lead sponsor.

NCT NCT04530955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS): A Randomized, Controlled, Multi-center, Prospective Study Evaluating Dose Reduction in ITB Patients.
Lead sponsor
Culicchia Neurological Clinic
Phase
Not applicable
Overall status
Unknown status
Start date
September 24, 2020
Completion date
June 30, 2023
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, spastic, cva (cerebrovascular accident), injuries, spinal cord, ms (multiple sclerosis), muscle spasticity, traumatic brain injury